High-level Management Lacks Direction - preclinical research associate II Translational Drug Development Employee Review

TD2 takes a different approach to client projects - science-led and with the view of the entire drug development ecosystem in mind. This is reflected and appreciated in client conversations and relationship with the BD team.

TD2 is a growing company and may not always have the latest technology or resources as a big CRO.

Flexible with time. No micromanaging, upper management trusts that you can do your job. I think most of the negative reviews are from the clinical side. As most CROs we’ve been affected by funding issues for clients leading to less work and this has been seen primarily on the clinical side leading to layoffs.

Layoffs and revenue issues from the clinical side of the company affect raises and promotions on the nonclinical side.